Symbol:
Epb42
Name:
erythrocyte membrane protein band 4.2
RGD ID:
1305306
Description:
Predicted to enable protein-glutamine gamma-glutamyltransferase activity. Predicted to act upstream of or within several processes, including hemoglobin metabolic process; multicellular organismal-level iron ion homeostasis; and spleen development. Predicted to be located in cortical cytoskeleton and membrane. Predicted to be part of ankyrin-1 complex. Human ortholog(s) of this gene implicated in hereditary spherocytosis and hereditary spherocytosis type 5. Orthologous to human EPB42 (erythrocyte membrane protein band 4.2); INTERACTS WITH 17beta-estradiol; 2,3,7,8-tetrachlorodibenzodioxine; 4,4'-sulfonyldiphenol.
Type:
protein-coding
RefSeq Status:
PROVISIONAL
Previously known as:
Epb4.2; erythrocyte protein band 4.2; LOC362202
RGD Orthologs
Alliance Orthologs
More Info
more info ...
More Info
Latest Assembly:
GRCr8 - GRCr8 Assembly
Position:
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 3 128,433,460 - 128,451,683 (-) NCBI GRCr8 mRatBN7.2 3 107,979,709 - 107,997,932 (-) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 3 107,979,713 - 107,997,932 (-) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 3 111,651,371 - 111,669,669 (-) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 3 120,246,950 - 120,265,248 (-) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 3 117,907,354 - 117,925,652 (-) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 3 112,967,095 - 112,985,318 (-) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 3 112,965,653 - 112,985,318 (-) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 3 119,509,972 - 119,528,195 (-) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 3 107,806,273 - 107,824,496 (-) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 RGSC_v3.1 3 107,703,057 - 107,723,679 (-) NCBI Celera 3 106,882,884 - 106,901,107 (-) NCBI Celera Cytogenetic Map 3 q35 NCBI
JBrowse:
View Region in Genome Browser (JBrowse)
Model
Only show annotations with direct experimental evidence (0 objects hidden)
Epb42 Rat 17beta-estradiol increases expression EXP 6480464 Estradiol results in increased expression of EPB42 mRNA CTD PMID:32145629 Epb42 Rat 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO Epb42 (Mus musculus) 6480464 [NR1I2 protein affects the susceptibility to 2 more ... CTD PMID:32352317 Epb42 Rat 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Epb42 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in increased expression of EPB42 mRNA CTD PMID:28213091 Epb42 Rat 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of EPB42 mRNA CTD PMID:33387578 Epb42 Rat 2-butoxyethanol increases expression ISO Epb42 (Mus musculus) 6480464 n-butoxyethanol results in increased expression of EPB42 mRNA CTD PMID:19812364 Epb42 Rat 4,4'-diaminodiphenylmethane increases expression ISO Epb42 (Mus musculus) 6480464 4 and 4'-diaminodiphenylmethane results in increased expression of EPB42 mRNA CTD PMID:18648102 Epb42 Rat 4,4'-sulfonyldiphenol multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of EPB42 mRNA CTD PMID:36041667 Epb42 Rat 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of EPB42 mRNA CTD PMID:24780913 Epb42 Rat aconitine increases expression EXP 6480464 Aconitine results in increased expression of EPB42 protein CTD PMID:33236894 Epb42 Rat acrylamide decreases expression EXP 6480464 Acrylamide results in decreased expression of EPB42 mRNA CTD PMID:28959563 Epb42 Rat aflatoxin B1 increases methylation ISO EPB42 (Homo sapiens) 6480464 Aflatoxin B1 results in increased methylation of EPB42 gene CTD PMID:27153756 Epb42 Rat aldehydo-D-glucose multiple interactions ISO Epb42 (Mus musculus) 6480464 [lard co-treated with Cholesterol and Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of EPB42 mRNA CTD PMID:37567420 Epb42 Rat benzo[a]pyrene increases methylation ISO EPB42 (Homo sapiens) 6480464 Benzo(a)pyrene results in increased methylation of EPB42 promoter CTD PMID:27901495 Epb42 Rat benzo[a]pyrene decreases methylation ISO Epb42 (Mus musculus) 6480464 Benzo(a)pyrene results in decreased methylation of EPB42 exon and Benzo(a)pyrene results in decreased methylation of EPB42 intron CTD PMID:27901495 Epb42 Rat bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of EPB42 mRNA CTD PMID:25181051 more ... Epb42 Rat bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of EPB42 mRNA CTD PMID:36041667 Epb42 Rat bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of EPB42 mRNA CTD PMID:32145629 and PMID:34947998 Epb42 Rat bisphenol F multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of EPB42 mRNA CTD PMID:36041667 Epb42 Rat calcium silicate increases expression ISO Epb42 (Mus musculus) 6480464 calcium silicate results in increased expression of EPB42 mRNA CTD PMID:29279043 Epb42 Rat CGP 52608 multiple interactions ISO EPB42 (Homo sapiens) 6480464 CGP 52608 promotes the reaction [RORA protein binds to EPB42 gene] CTD PMID:28238834 Epb42 Rat chlorpyrifos decreases expression ISO Epb42 (Mus musculus) 6480464 Chlorpyrifos results in decreased expression of EPB42 mRNA CTD PMID:37019170 Epb42 Rat D-glucose multiple interactions ISO Epb42 (Mus musculus) 6480464 [lard co-treated with Cholesterol and Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of EPB42 mRNA CTD PMID:37567420 Epb42 Rat dibutyl phthalate increases expression ISO Epb42 (Mus musculus) 6480464 Dibutyl Phthalate results in increased expression of EPB42 mRNA CTD PMID:21266533 Epb42 Rat dioxygen increases expression ISO Epb42 (Mus musculus) 6480464 Oxygen deficiency results in increased expression of EPB42 mRNA CTD PMID:22629407 Epb42 Rat dioxygen multiple interactions ISO Epb42 (Mus musculus) 6480464 Oxygen inhibits the reaction [Oxygen deficiency results in increased expression of EPB42 mRNA] CTD PMID:22629407 Epb42 Rat fructose multiple interactions ISO Epb42 (Mus musculus) 6480464 [lard co-treated with Cholesterol and Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of EPB42 mRNA CTD PMID:37567420 Epb42 Rat genistein decreases expression ISO Epb42 (Mus musculus) 6480464 Genistein results in decreased expression of EPB42 mRNA CTD PMID:21048042 Epb42 Rat gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of EPB42 mRNA CTD PMID:33387578 Epb42 Rat glucose multiple interactions ISO Epb42 (Mus musculus) 6480464 [lard co-treated with Cholesterol and Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of EPB42 mRNA CTD PMID:37567420 Epb42 Rat nitrofen increases expression EXP 6480464 nitrofen results in increased expression of EPB42 mRNA CTD PMID:33484710 Epb42 Rat oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of EPB42 mRNA and [Topotecan co-treated with oxaliplatin] results in decreased expression of EPB42 mRNA CTD PMID:25729387 Epb42 Rat oxaliplatin decreases expression EXP 6480464 oxaliplatin results in decreased expression of EPB42 mRNA CTD PMID:25729387 Epb42 Rat paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of EPB42 mRNA CTD PMID:33387578 Epb42 Rat T-2 toxin increases expression ISO EPB42 (Homo sapiens) 6480464 T-2 Toxin results in increased expression of EPB42 mRNA CTD PMID:34581912 Epb42 Rat tert-butyl hydroperoxide increases degradation ISO EPB42 (Homo sapiens) 6480464 tert-Butylhydroperoxide results in increased degradation of EPB42 protein CTD PMID:15040847 Epb42 Rat thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of EPB42 mRNA CTD PMID:34492290 Epb42 Rat topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of EPB42 mRNA and [Topotecan co-treated with oxaliplatin] results in decreased expression of EPB42 mRNA CTD PMID:25729387 Epb42 Rat topotecan decreases expression EXP 6480464 Topotecan results in decreased expression of EPB42 mRNA CTD PMID:25729387 Epb42 Rat triclosan increases expression ISO EPB42 (Homo sapiens) 6480464 Triclosan results in increased expression of EPB42 mRNA CTD PMID:30510588 Epb42 Rat triptonide increases expression ISO Epb42 (Mus musculus) 6480464 triptonide results in increased expression of EPB42 mRNA CTD PMID:33045310 Epb42 Rat valproic acid affects expression ISO Epb42 (Mus musculus) 6480464 Valproic Acid affects the expression of EPB42 mRNA CTD PMID:17292431
17beta-estradiol (EXP) 2,2',4,4',5,5'-hexachlorobiphenyl (ISO) 2,3,7,8-tetrachlorodibenzodioxine (EXP,ISO) 2-butoxyethanol (ISO) 4,4'-diaminodiphenylmethane (ISO) 4,4'-sulfonyldiphenol (EXP) 6-propyl-2-thiouracil (EXP) aconitine (EXP) acrylamide (EXP) aflatoxin B1 (ISO) aldehydo-D-glucose (ISO) benzo[a]pyrene (ISO) bisphenol A (EXP) bisphenol F (EXP) calcium silicate (ISO) CGP 52608 (ISO) chlorpyrifos (ISO) D-glucose (ISO) dibutyl phthalate (ISO) dioxygen (ISO) fructose (ISO) genistein (ISO) gentamycin (EXP) glucose (ISO) nitrofen (EXP) oxaliplatin (EXP) paracetamol (EXP) T-2 toxin (ISO) tert-butyl hydroperoxide (ISO) thioacetamide (EXP) topotecan (EXP) triclosan (ISO) triptonide (ISO) valproic acid (ISO)
Epb42 (Rattus norvegicus - Norway rat)
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 3 128,433,460 - 128,451,683 (-) NCBI GRCr8 mRatBN7.2 3 107,979,709 - 107,997,932 (-) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 3 107,979,713 - 107,997,932 (-) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 3 111,651,371 - 111,669,669 (-) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 3 120,246,950 - 120,265,248 (-) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 3 117,907,354 - 117,925,652 (-) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 3 112,967,095 - 112,985,318 (-) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 3 112,965,653 - 112,985,318 (-) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 3 119,509,972 - 119,528,195 (-) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 3 107,806,273 - 107,824,496 (-) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 RGSC_v3.1 3 107,703,057 - 107,723,679 (-) NCBI Celera 3 106,882,884 - 106,901,107 (-) NCBI Celera Cytogenetic Map 3 q35 NCBI
EPB42 (Homo sapiens - human)
Human Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCh38 15 43,197,227 - 43,225,737 (-) NCBI GRCh38 GRCh38 hg38 GRCh38 GRCh38.p14 Ensembl 15 43,197,227 - 43,221,018 (-) Ensembl GRCh38 hg38 GRCh38 GRCh37 15 43,489,425 - 43,513,216 (-) NCBI GRCh37 GRCh37 hg19 GRCh37 Build 36 15 41,276,720 - 41,300,773 (-) NCBI NCBI36 Build 36 hg18 NCBI36 Build 34 15 41,276,719 - 41,300,773 NCBI Celera 15 20,260,253 - 20,284,152 (-) NCBI Celera Cytogenetic Map 15 q15.2 NCBI HuRef 15 20,338,220 - 20,362,120 (-) NCBI HuRef CHM1_1 15 43,608,206 - 43,632,105 (-) NCBI CHM1_1 T2T-CHM13v2.0 15 41,004,516 - 41,033,028 (-) NCBI T2T-CHM13v2.0
Epb42 (Mus musculus - house mouse)
Mouse Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCm39 2 120,848,372 - 120,867,358 (-) NCBI GRCm39 GRCm39 mm39 GRCm39 Ensembl 2 120,848,372 - 120,867,553 (-) Ensembl GRCm39 Ensembl GRCm38 2 121,017,891 - 121,036,877 (-) NCBI GRCm38 GRCm38 mm10 GRCm38 GRCm38.p6 Ensembl 2 121,017,891 - 121,037,072 (-) Ensembl GRCm38 mm10 GRCm38 MGSCv37 2 120,843,953 - 120,862,491 (-) NCBI GRCm37 MGSCv37 mm9 NCBIm37 MGSCv36 2 120,709,658 - 120,728,196 (-) NCBI MGSCv36 mm8 Celera 2 122,170,412 - 122,188,962 (-) NCBI Celera Cytogenetic Map 2 E5 NCBI cM Map 2 60.37 NCBI
Epb42 (Chinchilla lanigera - long-tailed chinchilla)
Chinchilla Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChiLan1.0 Ensembl NW_004955416 9,784,260 - 9,798,194 (-) Ensembl ChiLan1.0 ChiLan1.0 NW_004955416 9,784,211 - 9,800,453 (-) NCBI ChiLan1.0 ChiLan1.0
EPB42 (Pan paniscus - bonobo/pygmy chimpanzee)
Bonobo Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl NHGRI_mPanPan1-v2 16 32,448,060 - 32,481,629 (-) NCBI NHGRI_mPanPan1-v2 NHGRI_mPanPan1 15 36,608,897 - 36,643,381 (-) NCBI NHGRI_mPanPan1 Mhudiblu_PPA_v0 15 22,157,831 - 22,183,254 (-) NCBI Mhudiblu_PPA_v0 Mhudiblu_PPA_v0 panPan3 PanPan1.1 15 40,313,462 - 40,337,458 (-) NCBI panpan1.1 PanPan1.1 panPan2 PanPan1.1 Ensembl 15 40,313,462 - 40,337,458 (-) Ensembl panpan1.1 panPan2
EPB42 (Canis lupus familiaris - dog)
Dog Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl CanFam3.1 30 10,065,352 - 10,085,021 (-) NCBI CanFam3.1 CanFam3.1 canFam3 CanFam3.1 CanFam3.1 Ensembl 30 10,065,469 - 10,084,976 (-) Ensembl CanFam3.1 canFam3 CanFam3.1 Dog10K_Boxer_Tasha 30 10,124,435 - 10,143,997 (-) NCBI Dog10K_Boxer_Tasha ROS_Cfam_1.0 30 10,201,518 - 10,221,080 (-) NCBI ROS_Cfam_1.0 ROS_Cfam_1.0 Ensembl 30 10,201,616 - 10,221,099 (-) Ensembl ROS_Cfam_1.0 Ensembl UMICH_Zoey_3.1 30 10,118,341 - 10,137,883 (-) NCBI UMICH_Zoey_3.1 UNSW_CanFamBas_1.0 30 10,239,312 - 10,258,862 (-) NCBI UNSW_CanFamBas_1.0 UU_Cfam_GSD_1.0 30 10,359,057 - 10,378,759 (-) NCBI UU_Cfam_GSD_1.0
Epb42 (Ictidomys tridecemlineatus - thirteen-lined ground squirrel)
Squirrel Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl HiC_Itri_2 NW_024408640 88,529,093 - 88,547,882 (-) NCBI HiC_Itri_2 SpeTri2.0 Ensembl NW_004936471 6,377,775 - 6,395,753 (-) Ensembl SpeTri2.0 SpeTri2.0 Ensembl SpeTri2.0 NW_004936471 6,377,232 - 6,393,588 (-) NCBI SpeTri2.0 SpeTri2.0 SpeTri2.0
EPB42 (Sus scrofa - pig)
Pig Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl Sscrofa11.1 Ensembl 1 128,231,997 - 128,253,031 (+) Ensembl Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa11.1 1 128,231,863 - 128,253,696 (+) NCBI Sscrofa11.1 Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa10.2 1 143,108,368 - 143,129,865 (+) NCBI Sscrofa10.2 Sscrofa10.2 susScr3
EPB42 (Chlorocebus sabaeus - green monkey)
Green Monkey Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChlSab1.1 26 39,770,288 - 39,794,252 (+) NCBI ChlSab1.1 ChlSab1.1 chlSab2 ChlSab1.1 Ensembl 26 39,770,664 - 39,794,173 (+) Ensembl ChlSab1.1 ChlSab1.1 Ensembl chlSab2 Vero_WHO_p1.0 NW_023666048 101,218,993 - 101,243,288 (-) NCBI Vero_WHO_p1.0 Vero_WHO_p1.0
Epb42 (Heterocephalus glaber - naked mole-rat)
.
Predicted Target Of
Count of predictions: 45 Count of miRNA genes: 41 Interacting mature miRNAs: 44 Transcripts: ENSRNOT00000015556 Prediction methods: Miranda, Rnahybrid, Targetscan Result types: miRGate_prediction
2312673 Scl63 Serum cholesterol level QTL 63 0.001 blood cholesterol amount (VT:0000180) serum total cholesterol level (CMO:0000363) 3 98535255 168026850 Rat 2301414 Kidm37 Kidney mass QTL 37 0.001 kidney mass (VT:0002707) both kidneys wet weight to body weight ratio (CMO:0000340) 3 70653097 121056321 Rat 2302373 Gluco39 Glucose level QTL 39 5.01 blood glucose amount (VT:0000188) blood glucose level area under curve (AUC) (CMO:0000350) 3 98535386 161695835 Rat 1582238 Bw68 Body weight QTL 68 3.2 0.0064 body mass (VT:0001259) body weight (CMO:0000012) 3 53184593 115665732 Rat 1582239 Epfw1 Epididymal fat weight QTL 1 4.5 0.0006 epididymal fat pad mass (VT:0010421) epididymal fat pad weight to body weight ratio (CMO:0000658) 3 53184593 115665732 Rat 70216 Cm14 Cardiac mass QTL 14 2.1 heart mass (VT:0007028) heart wet weight (CMO:0000069) 3 31172320 163586636 Rat 2292591 Esta4 Estrogen-induced thymic atrophy QTL 4 thymus mass (VT:0004954) thymus wet weight (CMO:0000855) 3 47233211 147415807 Rat 1358362 Srcrt2 Stress Responsive Cort QTL 2 2.78 blood corticosterone amount (VT:0005345) plasma corticosterone level (CMO:0001173) 3 38192233 133483320 Rat 1582216 Bw65 Body weight QTL 65 6.3 body mass (VT:0001259) body weight (CMO:0000012) 3 102200529 115665732 Rat 737818 Hcar12 Hepatocarcinoma resistance QTL 12 2.6 liver integrity trait (VT:0010547) volume of individual liver tumorous lesion (CMO:0001078) 3 29463235 118376539 Rat 1582218 Bw74 Body weight QTL 74 3.9 0.0021 body mass (VT:0001259) body weight (CMO:0000012) 3 53184593 115665732 Rat 1582219 Bw63 Body weight QTL 63 3.8 0.001 body mass (VT:0001259) body weight (CMO:0000012) 3 96127817 115665732 Rat 1582221 Kidm30 Kidney mass QTL 30 3.5 0.0008 kidney mass (VT:0002707) both kidneys wet weight (CMO:0000085) 3 64655305 115665732 Rat 1581568 Rf53 Renal function QTL 53 urine total protein amount (VT:0000032) urine protein excretion rate to body weight ratio (CMO:0001099) 3 56395968 161299569 Rat 1582210 Bw71 Body weight QTL 71 3.3 0.0012 body mass (VT:0001259) body weight (CMO:0000012) 3 64655305 115665732 Rat 7387306 Bw124 Body weight QTL 124 3.2 0.0003 body mass (VT:0001259) body weight (CMO:0000012) 3 84091273 129091273 Rat 1300111 Rf12 Renal function QTL 12 3.78 renal blood flow trait (VT:2000006) absolute change in renal blood flow rate (CMO:0001168) 3 61017749 121056321 Rat 724523 Tsu1 Thymus enlargement suppressive QTL 1 3.84 thymus mass (VT:0004954) thymus weight to body weight ratio (CMO:0000612) 3 50437504 115638231 Rat 1600376 Arunc5 Aerobic running capacity QTL 5 0.21 exercise endurance trait (VT:0002332) maximum distance run on treadmill (CMO:0001406) 3 73376539 118376539 Rat 8694437 Bw167 Body weight QTL 167 22.46 0.001 retroperitoneal fat pad mass (VT:0010430) retroperitoneal fat pad weight to body weight ratio (CMO:0000635) 3 91797474 136797474 Rat 2302273 Gluco35 Glucose level QTL 35 5.3 0.001 blood glucose amount (VT:0000188) blood glucose level (CMO:0000046) 3 80800231 114297550 Rat 8662816 Vetf4 Vascular elastic tissue fragility QTL 4 4 renal artery integrity trait (VT:0010642) number of ruptures of the internal elastic lamina of the renal arteries (CMO:0002563) 3 59242096 157323038 Rat 1559282 Emca5 Estrogen-induced mammary cancer QTL 5 3.9 mammary gland integrity trait (VT:0010552) percentage of study population developing mammary tumors during a period of time (CMO:0000948) 3 43827364 169034231 Rat 1581503 Cm58 Cardiac mass QTL 58 2.7 0.05 heart left ventricle mass (VT:0007031) heart left ventricle weight to body weight ratio (CMO:0000530) 3 43827364 121056321 Rat 1354611 Despr2 Despair related QTL 2 3.03 0.0028 locomotor behavior trait (VT:0001392) amount of time spent in voluntary immobility (CMO:0001043) 3 97084464 142084464 Rat 2292613 Ept16 Estrogen-induced pituitary tumorigenesis QTL 16 8.3 pituitary gland mass (VT:0010496) pituitary gland wet weight (CMO:0000853) 3 47233430 110362260 Rat 631649 Bp123 Blood pressure QTL 123 3.2 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 3 89772419 134772419 Rat 631841 Niddm39 Non-insulin dependent diabetes mellitus QTL 39 3.36 blood glucose amount (VT:0000188) blood glucose level (CMO:0000046) 3 94856903 159898684 Rat 619618 Rf3 Renal disease susceptibility QTL 3 6.5 0.001 urine albumin amount (VT:0002871) urine albumin excretion rate to body weight ratio (CMO:0001270) 3 107693393 152693393 Rat 12879848 Bw181 Body weght QTL 181 0.015 body mass (VT:0001259) body weight (CMO:0000012) 3 70348525 121056321 Rat 2312659 Slep7 Serum leptin concentration QTL 7 0.001 blood leptin amount (VT:0005667) serum leptin level (CMO:0000780) 3 98535255 168026850 Rat 2301971 Cm71 Cardiac mass QTL 71 4.63 heart left ventricle mass (VT:0007031) heart left ventricle weight (CMO:0000776) 3 41874578 155617519 Rat 2301970 Bw81 Body weight QTL 81 5.19 body mass (VT:0001259) body weight (CMO:0000012) 3 41874578 155617519 Rat 1358885 Bp251 Blood pressure QTL 251 3.8 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 3 14489145 121056321 Rat 1581546 Pur13 Proteinuria QTL 13 2.93 0.0335 urine total protein amount (VT:0000032) urine protein excretion rate (CMO:0000759) 3 78196190 146592722 Rat 631665 Bw8 Body weight QTL 8 5.5 body mass (VT:0001259) body weight (CMO:0000012) 3 50437042 119183768 Rat 1358888 Bp264 Blood pressure QTL 264 4.43 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 3 14489145 121056321 Rat 2312670 Bw94 Body weight QTL 94 0.01 inguinal fat pad mass (VT:0010424) inguinal fat pad weight to body weight ratio (CMO:0001253) 3 98535255 168026850 Rat 2293087 Iddm27 Insulin dependent diabetes mellitus QTL 27 2.68 blood glucose amount (VT:0000188) blood glucose level (CMO:0000046) 3 97551417 147415807 Rat 1358186 Ept2 Estrogen-induced pituitary tumorigenesis QTL 2 8.3 pituitary gland mass (VT:0010496) pituitary gland wet weight (CMO:0000853) 3 47233430 110362260 Rat 724532 Cm17 Cardiac mass QTL 17 2 heart mass (VT:0007028) calculated heart weight (CMO:0000073) 3 95735366 140735366 Rat
RH140989
Rat Assembly Chr Position (strand) Source JBrowse RH 3.4 Map 3 944.5 UniSTS Cytogenetic Map 3 q35 UniSTS
Click on a value in the shaded box below the category label to view a detailed expression data table for that system.
alimentary part of gastrointestinal system
9
11
49
113
91
90
59
25
59
6
218
97
93
45
60
31
Too many to show, limit is 500. Download them if you would like to view them all.
Ensembl Acc Id:
ENSRNOT00000015556 ⟹ ENSRNOP00000015556
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 3 107,979,713 - 107,997,932 (-) Ensembl Rnor_6.0 Ensembl 3 112,965,653 - 112,985,318 (-) Ensembl
Ensembl Acc Id:
ENSRNOT00000112520 ⟹ ENSRNOP00000085044
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 3 107,979,713 - 107,996,858 (-) Ensembl
RefSeq Acc Id:
NM_001108590 ⟹ NP_001102060
RefSeq Status:
PROVISIONAL
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 3 128,433,460 - 128,451,683 (-) NCBI mRatBN7.2 3 107,979,709 - 107,997,932 (-) NCBI Rnor_6.0 3 112,967,095 - 112,985,318 (-) NCBI Rnor_5.0 3 119,509,972 - 119,528,195 (-) NCBI RGSC_v3.4 3 107,806,273 - 107,824,496 (-) RGD Celera 3 106,882,884 - 106,901,107 (-) RGD
Sequence:
CTTTAAACCAGAAGTCCACCATCTTCGCCGGTGTGGAGGTAGATTTGGAGAGAGAATCCAGAGAGAAGCAACAGAGGGAGGTCAGCGTCTCCTGAGCTGTGGACTCAAGTAGCCTGCAGCCATGGGAC AAGCTCTGAGTATCAAGAGCTGCGACTTCCACGCAGCAGAAAACAACAAGGAGCACCACACCGACGCCATCAGCTCCCAGCACCTTATTTTGAGGAGGGGACAGTCCTTCACCATCACCCTGAACTTC CGTGCCCCGGCCCACATATTTCTGTCTGCCCTGAAGAAAGTGGCTCTCATTGCACAAACTGGAGAGCAACCTTCCAAGACCAGTAAGACCCAAGCCATATTCCCTATTTCCTCCCTGGGGGACAAAAA AGGGTGGAGTGCAGCAGTGGTGGAAAGAGATGCCCAACATTGGACCATCTCTGTGACCACGCCCGTGGATGCTGTCATTGGCCACTACTCACTCCTGCTTCAGGTTTCCGGCAAGAAACAATACCCCT TGGGCCAATTCACACTGCTCTTTAATCCATGGAATAGAGATGATGCTGTATTTCTGCAGAACGAGGTTCAACGCACTGAATATGTACTGAATCAGGATGGCTTTATCTACCTGGGCACAGCTGACTGC ATTCAAGAAGAGCCCTGGGACTTCGGTCAGTTTGAGAGAGACGTCATGGACCTCAGCCTGAACTTACTGAGTGTGGACAAGCAAGTGAAAGACTGGAGCCAGCCTGCACACGTGGCCTGCATAGTGGG CGCCTTGTTGCATGCCCTCAAGAAGAAGAGTGTCCTGCCTATTTCACAGACCCAGGCTGCCCAGCAAGGTGCCTTGTTGTACAAACGACGAGGCAGTGTGCCCATCCTGAGGCAGTGGCTCACTGGCC GAGGACGACCTGTGTATGAGAGCCAGGCGTGGGTGTTTGCTGCTGTTGCTTGCACAGTGCTACGATGCCTGGGCATCCCAGCTCGAGTTGTTACCACATTTGACTCAGCCCAAGGTACCAATGGGAGC CTGCTGGTGGATGAGTACTACAATGAGGAGGGGCTCCAGAATGGAGAAGGACAGAGGGGCCATATCTGGGTCTTCCAAACTTCTGTAGAATGCTGGATGAACAGACCTGATTTGTCCCCGGGTTATGA TGGATGGCAGATTCTGCACCCAAGAGCTCCTAATGGAGTTGGAGTCCTGGGATCCTGCAATCTGGTCCCAGTCAAAGCAGTCAAAGAGGGGGACCTGCAGCTGGACCCGGCAGTACCAGAGCTCTTTG CCGCAGTGAATGCCTCGTGCGTGGTCTGGAAGTGCTGTGAGGATGGGAAGTTGGAGTTGACCAACTCCAACAGAAAGAATGTTGGCAACAGCATCAGCACCAAGGTCGTGGGCAGTGACCGCTGCGAA GACATCACCCAGAACTACAAATATCCTGAAGGATCTCTTCAAGAAAAGGAGGTACTGGAGAGAGTCCAAAAAGAAAGAATGAAACTTGGGGAAGACACGTGTCCTCCTAGTTGTGAGCCTGGGGATCC TCTGCACCTGTTCTTGGAAGTACCTAGCTCCCAGCCTCTGAGAGGAAATGGTCGGCTCTCAGTGGCCTTGATTAACCCCACAGACAAGGAGAAGGAGGTAGAACTGGTGATTGCGGCCCAGGCTTTGT ACTACAATGGAGTCCTTGCTACTGGGCTCTGGAGGCAGAAGCAGTTCCTCATGCTCGGACCCAACCAGGTTCTGAGACTCTCCACCAGCCTGTCCTTCTCCTGTTTCGAACAAAACCCACCTGAGAAC ACCTTTCTCAGAGTCACAGCAATGGCAAGGCACTCCCACGCTGGCTTCAGCTGCTTTGCTCAGGAAGATGTGGTCATCAGTAGACCGAATCTTGTCATTGAGATGCCAAAGAGAGCAACACAGTATCA GCCCCTTACTGCCTCAGTTAGAATGCACAACTCCTTAGACGCCCCCATGCAGAACTGCATCATCTCCATCTTTGGAAGGGGACTCATTCACAGAGAAAAGAGATACGGATTGGGTTCTGTGTGGCCAG GAAGCAGCCTGCATACTCAGTTCCAGTTCACCCCAACACATCTGGGGCTCCAAAGGCTCACTGTGGAAGTAGATTGTGACATGTTCCAGAACCTGACCGGCCACAGAAGTGTCCTTGTGGTGGCCCCT GAAGTTTCTGTTTAAACTCCAAACAACCTTCAGACTTCTAAAGCTAGACATGCTCCAGAGGGAAACTCTACCTATCAGACAAATGAGTCTATACTAAAGTTGAACAGACCGGTGACCAAAAACCAAAA TTCATTTTTTTCTTGTTTTTTTTTGGGGGGGTGGTTTGTTTTTGTTTGTTTGTTTGTTTGTTTTTGTTGTTGTTGTTTTTTGGTTATTTGGTGGGTATTTTCGAAACAGAGTTTCTCTATGTAGTCCT GGTGGTCCTGGAACTCACGCTGTAGATCAGGCTGGCCTTGAACTCAGAGATCCACCTGCCTCTCCCTCCCGAGTGCTTCCATTAAAGGCATGTGCCACCATTGTCTGGCTCCAAAAAAAAAAAAAAAA AAAAAAAA
hide sequence
RefSeq Acc Id:
NP_001102060 ⟸ NM_001108590
- UniProtKB:
B5DF57 (UniProtKB/TrEMBL), A6HPL9 (UniProtKB/TrEMBL), A0A8I5ZZB1 (UniProtKB/TrEMBL), F7F1R4 (UniProtKB/TrEMBL)
- Sequence:
MGQALSIKSCDFHAAENNKEHHTDAISSQHLILRRGQSFTITLNFRAPAHIFLSALKKVALIAQTGEQPSKTSKTQAIFPISSLGDKKGWSAAVVERDAQHWTISVTTPVDAVIGHYSLLLQVSGKKQ YPLGQFTLLFNPWNRDDAVFLQNEVQRTEYVLNQDGFIYLGTADCIQEEPWDFGQFERDVMDLSLNLLSVDKQVKDWSQPAHVACIVGALLHALKKKSVLPISQTQAAQQGALLYKRRGSVPILRQWL TGRGRPVYESQAWVFAAVACTVLRCLGIPARVVTTFDSAQGTNGSLLVDEYYNEEGLQNGEGQRGHIWVFQTSVECWMNRPDLSPGYDGWQILHPRAPNGVGVLGSCNLVPVKAVKEGDLQLDPAVPE LFAAVNASCVVWKCCEDGKLELTNSNRKNVGNSISTKVVGSDRCEDITQNYKYPEGSLQEKEVLERVQKERMKLGEDTCPPSCEPGDPLHLFLEVPSSQPLRGNGRLSVALINPTDKEKEVELVIAAQ ALYYNGVLATGLWRQKQFLMLGPNQVLRLSTSLSFSCFEQNPPENTFLRVTAMARHSHAGFSCFAQEDVVISRPNLVIEMPKRATQYQPLTASVRMHNSLDAPMQNCIISIFGRGLIHREKRYGLGSV WPGSSLHTQFQFTPTHLGLQRLTVEVDCDMFQNLTGHRSVLVVAPEVSV
hide sequence
Ensembl Acc Id:
ENSRNOP00000015556 ⟸ ENSRNOT00000015556
Ensembl Acc Id:
ENSRNOP00000085044 ⟸ ENSRNOT00000112520
Date
Current Symbol
Current Name
Previous Symbol
Previous Name
Description
Reference
Status
2008-04-30
Epb4.2
erythrocyte protein band 4.2
Epb4.2_predicted
erythrocyte protein band 4.2 (predicted)
'predicted' is removed
2292626
APPROVED
2005-01-12
Epb4.2_predicted
erythrocyte protein band 4.2 (predicted)
Symbol and Name status set to approved
70820
APPROVED